Urine cytology in the evaluation of urological malignancy revisited: Is it still necessary?

Urologia Internationalis

Volumn 84, Issue 1, 2010, Pages 45-49

  Falebita, Opeyemi Adegboyega ^a   Lee, Garry ^a   Sweeney, Paul ^a  

^a MERCY UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Cost; Cytology; Malignancy; Urine

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; BLADDER TRANSITIONAL CARCINOMA; BLADDER TUMOR; CANCER CELL; CLINICAL EVALUATION; COST; COST EFFECTIVENESS ANALYSIS; CYSTOSCOPY; DATA BASE; DIAGNOSTIC IMAGING; FEMALE; HOSPITAL DEPARTMENT; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; PROSTATE CANCER; RADIODIAGNOSIS; RETROSPECTIVE STUDY; SEX; URETER CARCINOMA; URETERIC TRANSITIONAL CELL CARCINOMA; URINARY TRACT CANCER; URINE CYTOLOGY;

AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; CYSTOSCOPY; FALSE POSITIVE REACTIONS; FEMALE; HEMATURIA; HUMANS; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; URINARY BLADDER NEOPLASMS; UROLOGY;

EID: 77649139901     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000273465     Document Type: Article

References (29)

1. Nabi G, Greene D, Donnel MO: Suspicious urinary cytology with negative evaluation for malignancy in the diagnostic investigation of haematuria: how to follow up? J Clin Pathol 2004; 57: 365-368.
2. Sanders WR: Cancer of the bladder fragments forming urethra plugs discharged in urine: concentric colloid bodies. Edinburgh J Med 1864; 10: 273-274.
3. Papanicolaou GN, Marshal VF: Urine sediment smears: a diagnostic procedure in cancers of urinary tract. Science 1945; 101: 519-520.
4. Raghavan D, Shipley WU, Garnick MB, Russell PJ, Richie JP: Biology and management of bladder cancer. N Engl J Med 1990; 322: 1129-1138.
5. Grossfeld GD, Wolf JS Jr, Litwan MS, Hricak H, Schuler CL, Agerter DC, Carroll PR: Asymptomatic microscopic hematuria in adults: summary of the AUA best practice policy recommendations. Am Fam Physician 2001; 63: 1145-1154.
6. Nabi G, Greene DR, O'Donnell M: How important is urinary cytology in the diagnosis of urological malignancies? Eur Urol 2003; 43: 632-636.
7. Lamm DL: Carcinoma in situ. Urol Clin North Amer 1992; 19: 499-508.
8. Wiener HG, Mian C, Haital A, et al. Can urine bound diagnostic tests replace cystoscopy in the management of bladder cancer? J Urol 1998; 159: 1876-1880.
9. Johnston B, Morales A, Emerson L, et al. Rapid detection of bladder cancer: a comparative study of point care tests. J Urol 1997; 158: 2098-2101.
10. Kannan V, Gupta D: Calculus artefact. A challenge in urinary cytology. Acta Cytol 1999; 43: 794-800.
11. Maier U, Shank R, Neuhold N: The clinical value of urinary cytology: 12 years of experience with 615 patients. J Clin Pathol 1995; 48: 314-317.
12. Murphy WM, Soloway MS, Jukkola AF, Crabtree WN, Ford KS: Urinary cytology and bladder cancer. The cellular features of transitional cell neoplasms. Cancer 1984; 53: 1555-1565.
13. Herr HW, Regan M: Urine cytology after flexible cystoscopy. BJU Int 2005; 96: 796-797.
14. Talwar R, Sinha T, Karan SC, et al: Voided urinary cytology in bladder cancer: is it time to review the indications? Urology 2007; 70: 267-271.
15. Cross SS, Stone JL: Proactive management of histopathology workload: analysis of the UK Royal College of Pathologists recommendations on specimens of limited or no clinical value on the workload of a teaching hospital gastrointestinal pathology services. J Clin Pathology 2002; 55: 850-852.
16. Lotan Y, Roehrborn CG: Sensitivity and specificity of commonly available bladder tumour markers versus cytology: results of a comprehensive literature review and metaanalysis. Urology 2003; 61: 109-118.
17. Halling KC, King W, Sokolova IA, Meyer RG, Burkhardt HM, Halling AC, et al: A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma. J Urol 2000; 164: 1768-1775.
18. Viswanath S, Zelhof B, Ho E, Sethia K, Mills R: Is routine urine cytology useful in the haematuria clinic? Ann R Coll Surg Engl 2008; 90: 153-155.
19. Ishiwata S, Takahashi S, Homma Y, et al: Non-invasive detection and prediction of bladder cancer by fluorescence in situ hybridization analysis of exfoliated urothelial cells in voided urine. Urology 2001; 57: 811-815.
20. Murphy WM, Soloway MS, Jukkola AF, Crabtree WN, Ford KS: Urinary cytology and bladder cancer. The cellular features of transitional cell neoplasms. Cancer 1984; 53: 1555-1565.
21. Frimberger D, Zaak D, Hofstetter A: Endoscopic fluorescence diagnosis and laser treatment of transitional cell carcinoma. Semin Urol Oncol 2000; 18: 264-272.
22. Hudson MA, Herr HW: Carcinoma in situ of the bladder. J Urol 1995; 153: 564-572.
23. Planz B, Jochims E, Deix T, Caspers HP, Jakse G, Boecking A: The role of urinary cytology for detection of bladder cancer. Eur J Surg Oncol 2005; 31: 304-308.
24. Pattari SK, Dey P: Urine: beyond cytology for detection of malignancy. Diagn Cytopathol 2002; 27: 139-142.
25. Soloway MS, Briggman JV, Carpinito GA, et al: Use of new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment. J Urol 1996; 156: 363-367.
26. Miyanaga N, Akaza HI, Shikawa S, et al: Clinical evaluation of nuclear matrix protein in urine as a novel marker for urothelial cancer. Eur Urol 1997; 31: 163-168
27. Howat A, Boyd K, Douce G, et al: SAC on histopathology working group on histopathology of limited or no clinical value. Royal College of Pathologists. Report of working group, 2002, pp 1-14.
28. Paez A, Coba JM, Murillo N, Fernandez P, de la Cal MA, Lujan M: Reliability of urine cytology in the cytological diagnosis of bladder cancers. Eur Urol 1999; 35: 228-232.
29. Blake MA, Kaira MK: Imaging of urinary tract tumors. Cancer Treat Res 2008; 143: 299-317.